We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-1.91%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$151M
AUM Growth
+$10.1M
Cap. Flow
+$16.3M
Cap. Flow %
10.8%
Top 10 Hldgs %
48.77%
Holding
155
New
39
Increased
47
Reduced
18
Closed
28

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$8.86M
2
KSU
Kansas City Southern
KSU
+$3.59M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$3.54M
4
PPD
PPD, Inc. Common Stock
PPD
+$3.47M
5
FIVN icon
FIVE9
FIVN
+$3.18M

Top Sells

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$9.44M
2
MXIM
Maxim Integrated Products
MXIM
+$4.49M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.96M
4
WORK
Slack Technologies, Inc.
WORK
+$3.57M
5
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 44.08%
2 Technology 31.3%
3 Consumer Discretionary 7.05%
4 Communication Services 3.66%
5 Industrials 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
51
Fate Therapeutics
FATE
$318M
$1.02M 0.67%
17,134
+6,006
+54% +$471K
IGMS
52
DELISTED
IGM Biosciences
IGMS
$1.02M 0.67%
15,446
+4,965
+47% +$380K
BEAM icon
53
Beam Therapeutics
BEAM
$2.8B
$998K 0.66%
+11,474
New +$1.15M
LENZ
54
LENZ Therapeutics
LENZ
$167M
$998K 0.66%
+8,701
New +$1.29M
SWTX
55
DELISTED
SpringWorks Therapeutics
SWTX
$989K 0.65%
15,594
+4,963
+47% +$382K
RPTX
56
DELISTED
Repare Therapeutics
RPTX
$947K 0.63%
+36,104
New +$1.17M
VERV
57
DELISTED
Verve Therapeutics
VERV
$883K 0.58%
+18,782
New +$1.1M
SNDX icon
58
Syndax Pharmaceuticals
SNDX
$1.81B
$872K 0.58%
45,584
-2,230
-5% -$37.2K
DBC icon
59
Invesco DB Commodity Index Tracking Fund
DBC
$1.72B
$856K 0.57%
42,396
– –
ATHM icon
60
Autohome
ATHM
$2.65B
$728K 0.48%
15,521
-15,433
-50% -$729K
AVIR icon
61
Atea Pharmaceuticals
AVIR
$403M
$724K 0.48%
20,659
-16,636
-45% -$461K
OCUL icon
62
Ocular Therapeutix
OCUL
$2.12B
$691K 0.46%
69,062
+7,423
+12% +$83.4K
YUMC icon
63
Yum China
YUMC
$16.2B
$684K 0.45%
11,771
+2,893
+33% +$178K
APLS
64
DELISTED
Apellis Pharmaceuticals
APLS
$651K 0.43%
+19,763
New +$1.11M
EWTX icon
65
Edgewise Therapeutics
EWTX
$4.87B
$650K 0.43%
39,133
+11,666
+42% +$211K
RVMD icon
66
Revolution Medicines
RVMD
$44.5B
$650K 0.43%
23,637
-1,401
-6% -$40.8K
BIDU icon
67
Baidu
BIDU
$36B
$622K 0.41%
4,043
-164
-4% -$26.9K
FMTX
68
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$619K 0.41%
26,711
-1,974
-7% -$46.7K
OLMA icon
69
Olema Pharmaceuticals
OLMA
$911M
$579K 0.38%
20,999
-8,123
-28% -$219K
NRIX icon
70
Nurix Therapeutics
NRIX
$2.73B
$563K 0.37%
18,796
-10,584
-36% -$327K
PTGX icon
71
Protagonist Therapeutics
PTGX
$9.66B
$501K 0.33%
28,311
+2,458
+10% +$105K
SPRY icon
72
ARS Pharmaceuticals
SPRY
$582M
$224K 0.15%
22,434
-3,472
-13% -$85.6K
SPOK icon
73
Spok Holdings
SPOK
$240M
$160K 0.11%
15,666
+3,374
+27% +$30.3K
GRTS
74
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$156K 0.1%
+14,453
New +$132K
ALPN
75
DELISTED
Alpine Immune Sciences Inc
ALPN
$152K 0.1%
+14,268
New +$131K
1 2
3
4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
BCC
Bridge City Capital Lake Oswego, Oregon $361M AUM 38.29% 1-Year Est. Return

HighVista Strategies's Q3 2021 Portfolio in Review

As of Q3 2021, HighVista Strategies held 155 positions worth $151M, up 7.2% from $141M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HighVista Strategies deployed $16.3M of net new capital in Q3 2021, opening 39 new positions and adding to 47 existing holdings. Its largest new stake was Coupang: 256,264 shares worth $7.14M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $1.39M trimmed.

  • HighVista Strategies's largest Q3 2021 buy was Coupang: 256,264 shares worth $7.14M.
  • HighVista Strategies added most to ESSA Pharma in Q3 2021, an estimated $1.9M increase.
  • HighVista Strategies's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.39M.
  • HighVista Strategies fully exited Willis Towers Watson in Q3 2021, selling an estimated $9.44M.
  • HighVista Strategies's ten largest holdings make up 49% of its $151M portfolio in Q3 2021.
  • HighVista Strategies opened 39 new positions and closed 28 in Q3 2021.
  • HighVista Strategies's portfolio value rose 7.2% quarter-over-quarter to $151M.

Based on HighVista Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.